AGC
ELV icon

Aspen Grove Capital’s Elevance Health ELV Stock Holding History

Aspen Grove Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-398
Closed -$204K – 162
2022
Q4 		$204K Buy
+398
New +$202K 0.09% 145

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Aspen Grove Capital's ELV Position: Q1 2023 in Review

Aspen Grove Capital sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 398 shares — an estimated $204K sold.

Aspen Grove Capital first reported a position in ELV in Q4 2022 and held it in 1 quarter. The position peaked at $204K in Q4 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Aspen Grove Capital reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Aspen Grove Capital sold 398 Elevance Health shares in Q1 2023, an estimated $204K.
  • Aspen Grove Capital first reported a position in Elevance Health in Q4 2022 and held it in 1 quarter.
  • Aspen Grove Capital's Elevance Health position peaked at $204K in Q4 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Aspen Grove Capital's 13F filing for Q1 2023, filed 15 May 2023.